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showed a bias of 1.6 l/min with limits of agreement of -1.76 l/min and +4.98 l/min. The percentage error
for COesCCO was 47%. The correlation of trends in cardiac output after eight hours was significant
(r = 0.442), with a concordance of 74%. The performance of COesCCO could not be linked to the
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Purpose. Estimation of cardiac output (CO) and evaluation of change in CO as a result of therapeutic interventions are essential in
critical care medicine. Whether noninvasive tools estimating CO, such as continuous cardiac output (esCCOTM) methods, are
sufficiently accurate and precise to guide therapy needs further evaluation. We compared esCCOTM with an established method,
namely, transpulmonary thermodilution (TPTD). Patients and Methods. In a single center mixed ICU, esCCOTM was compared
with the TPTD method in 38 patients. 'e primary endpoint was accuracy and precision. 'e cardiac output was assessed by two
investigators at baseline and after eight hours. Results. In 38 critically ill patients, the two methods correlated significantly
(r� 0.742). 'e Bland–Altman analysis showed a bias of 1.6 l/min with limits of agreement of −1.76 l/min and +4.98 l/min. 'e
percentage error for COesCCO was 47%. 'e correlation of trends in cardiac output after eight hours was significant (r� 0.442),
with a concordance of 74%.'e performance of COesCCO could not be linked to the patient’s condition. Conclusion. 'e accuracy
and precision of the esCCOTM method were not clinically acceptable for our critical patients. EsCCOTM also failed to reliably
detect changes in cardiac output.
1. Introduction
'e hemodynamic monitoring of critical care patients with
hypovolemia, myocardial dysfunction, or alterations in vas-
cular tone is essential in assessing their condition and tailoring
volume and the vasoactive therapy [1]. Continuous bedside
monitoring of cardiac output (CO) allows the recording of
changes in cardiac function and evaluation of responses to the
therapy, such as volume challenges or administration of
medication [1]. While several techniques for assessing he-
modynamic function already exist [2], noninvasive or mini-
mally invasive methods are emerging. 'e pulmonary artery
catheter (PAC) is considered the gold standard method for
monitoring cardiac output, but it is associated with the risks of
central venous catheterization (e.g., dysrhythmias) and
catheter residence (e.g., venous thrombosis, pulmonary
embolism and infarction, pulmonary artery rupture, and
sepsis [3]) and fails to record CO stroke by stroke. 'e
widespread use of PAC decreased after its benefit was
questioned in a systematic review [4]. Potentially less-invasive
devices, such as PiCCOTM (Pulsion Medical Systems, Ger-
many), have been considered preferable by some institutions
[5]. 'e PiCCOTM is an intermittent transpulmonary ther-
modilution (TPTD) based on periodical calibration and the
arterial pulse contour analysis for continuous, stroke by stroke
estimation of CO. Acceptable agreement on the estimation of
CO by TPTD and PAC was found in critically ill patients [6]
and between the arterial pulse contour analysis and TPTD in
hemodynamically unstable patients [7]. However, as PiC-
COTM requires the placement of a central venous catheter
and a femoral artery catheter, complications of cannulation
have to be considered [8, 9].
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'e survival benefit due to CO monitoring is still un-
certain [5, 10], and efforts to develop minimally invasive
devices allowing estimation of CO are ongoing. One of these
is VismoTM (Nihon Kohden, Japan), a device that con-
tinuously estimates the CO (esCCOTM) based on the pulse
wave transit time (PWTT) method. 'e PWTT is in theory
inversely correlated with the left ventricular stroke volume
[11]. It measures the time between the R-Wave in the
electrocardiogram and the appearance of the pulse wave by
pulse oximetry on a finger. 'e validity of the technique
needs to be assessed in an ICU population, and its impact on
outcome, if used to guide therapeutic decisions, is uncertain
[2].
As a noninvasive method allowing continuous estima-
tion of CO, the esCCOTM technique represents an alter-
native to more invasive monitoring methods. However,
whether it shows acceptable accuracy and precision and
whether it can properly detect changes in CO in ICU pa-
tients remains to be established. 'is study therefore
compares esCCOTM estimated by VismoTM to the CO
determined by PiCCOTM and tests whether the two devices
show similar efficacy in detecting a change in CO in a mixed
ICU population.
2. Material and Methods
2.1. Patients. Patients hospitalized from January to De-
cember 2016 in a critical care unit at the University Hospital
Zurich with invasive hemodynamic monitoring in place
were eligible for this study.'e study protocol was approved
by the Ethics Committee Zurich (KEK-ZH-No. 2016-0666)
and was designed in accordance with the Declaration of
Helsinki. Patients were eligible if between 18 and 100 years
of age and if they already had a PiCCOTM system and a
central venous catheter in place. Noninvasive blood pressure
measurement had to be taken on one arm, and ECG elec-
trodes and finger pulse oximetry needed to be attached.
Patients with a diagnosis of aortic aneurysm, atrial fibril-
lation, or ventricular arrhythmia were excluded, as were
pregnant women. In addition, patients were excluded if
scheduled for mobilization out of bed during the study
period or if allergic to any components of the equipment
used for the study. Written informed consent was obtained
from all patients or their next of kin.
2.2. Study Procedures. Patients included were assigned to
one of three predefined subgroups (“sepsis,” “polytrauma,”
or “nonsepsis/nonpolytrauma”) according to their diagno-
sis. Using the electronic patient file (KISIM, Cistec, Zurich,
Switzerland), concomitant diagnoses and the simplified
acute physiology score 2 (SAPS II) were registered.'e SAPS
II score is a scoring system for the predicted average ICU
mortality and is regularly calculated in the first 24 hours of
ICU admission [12]. For study purposes, the SAPS II score
was calculated again at the time of first measurement. 'e
variables heart rate, arterial blood pressure (systolic, dia-
stolic, and mean), respiratory rate, and saturation of pe-
ripheral oxygen (SpO2) were assessed via the PiCCOTM
monitor. At baseline, the esCCOTM system was applied
(three ECG electrodes, one blood pressure cuff, and a one
finger pulse oximeter). 'e PiCCOTM device was recali-
brated according to manufacturer’s standard. For calibration
of the esCCOTM, the investigator entered gender, age,
height, and weight of the patient and ran a noninvasive
blood pressure measurement. CO was then documented
from both the PiCCOTM and the VismoTM (Mbaseline #1).
'is initial procedure was repeated by a second investigator
(Mbaseline #2). At least one of the two investigators was a
senior ICU physician. After 8 hours, CO was obtained from
both devices (M8 h). After M8 h, the VismoTM device was
removed, and the study phase was finished.
2.3. Statistical Analysis. A sample size of 40 patients was
chosen to limit the total width of the 95% confidence interval of
the percentage error to 15%, calculated on a hypothetical per-
centage error of 30% and mean cardiac output of 5 l/min [13].
For descriptive statistics, categorical variables were
expressed as absolute numbers with percentages, normally
distributed quantitative variables as mean± standard devi-
ation (SD) and nonnormally distributed variables as median
with interquartile range (IQR). For the data analysis, the
mean ofMbaseline #1 andMbaseline #2 (Mmean baseline) was used
to minimize interobserver variability. Linear correlation
between COesCCO and COTPTD was assessed with the
Pearson product-moment correlation coefficient (r).
Agreement between methods of measurement was calcu-
lated using the Bland–Altman analysis. Accuracy is repre-
sented by the mean difference between COesCCO and
COTPTD (bias). Precision is represented by the standard
deviation (SD) of difference in CO in one device at one time
point. Limits of agreement (LoA) are calculated as bias
+1.96× SD (upper LoA) and bias −1.96× SD (lower LoA).
'e percentage error (1.96× SD of difference in CO/mean
CO of the two methods× 100%) was considered clinically
acceptable if it was lower than 30% [14]. 95% confidence
intervals (95% CI) were calculated for the Bland–Altman









, where n is the sample size. 95% CI
for the percentage error was calculated as (upper 95% CI
limit of the upper LoA− bias)/mean CO× 100% and (lower
95% CI limit of the upper LoA −bias)/mean CO× 100% [13].
Interobserver variability betweenMbaseline #1 andMbaseline #2
was evaluated by the Bland–Altman analysis.
Trending ability was assessed between cardiac output
after calibration (Mmean baseline) and after 8 hours (M8 h)
using a four-quadrant plot and the Pearson product-mo-
ment correlation coefficient (r). Concordance rate was
calculated as percentage of all cases when the trends
(ΔCOesCCO and ΔCOTPTD) were in the same direction. A
concordance rate of 90–95% was considered a reliable
trending ability [15].
All tests were two-sided, and a p value <0.05 was
considered statistically significant. 'e statistical analysis
was performed using SPSS Statistics version 23 (IBM Cor-
poration, Armonk, NY, USA). Raw data are provided
(supplementary data (available here)).
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3. Results
3.1. Patients. From January 1st, 2016 to December 31st, 2016,
a total of 1,689 patients were treated in our ICUs. Hemo-
dynamic monitoring with PiCCOTM was implemented in
128 patients. Of those, 40 patients fulfilled the inclusion
criteria and consented to be enrolled in the study. One
patient was excluded because of consent withdrawal before
the first measurement. In another patient, the PiCCOTM
measurements failed. Consequently, the data analysis was
performed for 38 patients. Data for the 8-hour follow-up
measurement were available from 34 patients. Missing the
follow-up resulted from death in one patient, measurement
failure of the VismoTM device in one patient, and in two
patients, the necessary removal of the PiCCOTM-line. Of
the 38 patients enrolled, 26 (68%) were male.'emedian age
was 62 (IQR: 50–72) years. Indications for hemodynamic
monitoring were sepsis in 13 (34%) cases, polytrauma in 6
(16%) cases, sepsis and polytrauma in 1 (3%) case, and
neither sepsis nor polytrauma in 18 (47%) cases. Patients’
characteristics are provided in Table 1.
3.2. Agreement between the Two Methods. To test for pre-
cision, CO measured by PiCCOTM (COTPTD) was com-
pared with CO estimated by VismoTM (COesCCO). 'e
average CO measurements at baseline (Mmean baseline) by
COTPTD correlated significantly with COesCCO estimates
(r� 0.742, p< 0.001, Figure 1(a)).'e bias on an average was
1.6 l/min (95% CI of 1.1 l/min to 2.2 l/min) with a lower LoA
of −1.76 l/min (95% CI of −2.71 l/min to −0.81 l/min) and an
upper LoA of +4.98 l/min (95% CI of +4.03 l/min to
+5.92 l/min) (Figure 1(b)). 'e percentage error was 47%
(95% CI of 34% to 60%).
To test for interobserver variability, a patient’s CO
assessed by a senior ICU physician was compared with that
assessed by another physician. Mean bias between observers
was −0.3 l/min for COTPTD and −0.1 l/min for COesCCO.
Corresponding limits of agreement were −1.9 l/min and
+1.3 l/min and −1.7 l/min and +1.5 l/min, respectively.
3.3. Trending Ability. To test whether methods reported a
change in CO similarly, CO assessed at baseline (Mmean
baseline) was compared with CO after 8 hours (M8 h). Cor-
relation between 8-hour trends of COesCCO (ΔCOesCCO) and
COTPTD (ΔCOTPTD) was significant (r� 0.442, p � 0.009;
Figure 1(c)). In all, 19.5% of changes in CO measured with
esCCOTM accounted for changes in CO measured with
TPTD (r2�19.5%).'e concordance rate of trends was 74%.
3.4. Performance in Patients with Sepsis, Polytrauma, and
Other Conditions. Comparisons between techniques were
planned for 3 predefined subgroups: patients with sepsis,
patients with polytrauma, and patients with neither sepsis
nor polytrauma.
Among 18 patients with neither sepsis nor polytrauma,
COesCCO and COTPTD correlated significantly (r� 0.669,
p � 0.002) with a percentage error of 53% (Figure 2(d)).
Among the subgroup of patients with sepsis (n� 13), the two
CO estimates correlated significantly (r� 0.813, 0.001) with a
percentage error of 49% (Figure 2(a)), whereas the 6 patients
with polytrauma were not analyzed as planned because of
the small group size. 'e one patient with polytrauma and
sepsis was excluded from analyzes. COesCCO as compared to
COTPTD underestimated CO in all subgroups (Figures 2(b)
and 2(e)), and analyzing trends in subgroups was not sig-
nificant (Figures 2(c) and 2(f )).
4. Discussion
'is prospective controlled study compares noninvasive
esCCOTM estimates with CO assessed by transpulmonary
thermodilution. In our mixed ICU population, the two
techniques had poor agreement with a bias of 1.6 l/min and
broad limits of agreement, a lower LoA of −1.76 l/min, and
an upper LoA of +4.98 l/min. 'e percentage error of
esCCOTM was 47% and thus not acceptable for clinical use.
We found that esCCOTM fails to detect changes in cardiac
output, as the concordance rate of trends was as low as 74%.
Similarly, changes in cardiac output estimated by TPTD only
predicted 19.5% of the changes observed by esCCOTM.
Dividing the study population into predefined subgroups
according to underlying condition identified patients with
sepsis to be best suited for CO estimation by esCCOTM.
To our knowledge, this is the first study, apart from
studies of patients undergoing anesthesia, to compare the
pulse-wave transition time method esCCOTM with TPTD
in a mixed ICU population. Reliable noninvasive tools for
monitoring cardiac function are highly desirable [2].
However, techniques currently available and evaluated for
clinical practice allow intermittent measurement of cardiac
output (e.g., echocardiography) or need invasive calibration
(e.g., the pulse-contour analysis with transpulmonary
thermodilution). It can be assumed that noninvasive
methods offer several potential advantages such as the
following: use without extensive training, screening of pa-
tients in need of invasive monitoring, and immediate benefit
from the volume therapy based on cardiac output, use in
primary and secondary transport, and reduction of com-
plications associated with invasive procedures and catheters.
Noninvasive devices are, in theory, easy and fast to install. In
practice, our investigators sometimes needed up to two
hours to obtain the first measurement, because the Vis-
moTM device failed to calculate the cardiac output. As the
esCCOTMmethod appears to offer all these advantages, our
goal was to investigate its interchangeability with our current
standard hemodynamic monitor PiCCOTM.
Our first goal was to analyze the accuracy and precision
of esCCOTM compared with TPTD in critically ill patients.
Our data showed a strong correlation between COTPTD and
COesCCO (r� 0.742), in concordance with various previous
studies that compared COesCCO with CO from pulmonary
artery catheter thermodilution [16–18] and transthoracic
echocardiography [19, 20]. However, the bias of esCCOTM
in the Bland–Altman analysis (Figure 1(b)) was high (1.6 l/
min) and its range of agreement was broad (−1.76 l/min;
+4.98 l/min), indicating low accuracy and low precision for
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this method in our study population, and thus rendering the
device clinically unacceptable for ICU patients. Yamada
et al. [16], Terada et al. [17], and Mansencal et al. [21] re-
ported the accuracy and precision superior to our findings.
As the study of Terada et al. [17] included intraoperative
patients only, their findings may not be generalizable to
critical care patients. Another study used cardiac output
from thermodilution for calibration of esCCOTM [16] but
still reported relatively large 95% prediction intervals of
−2.13 to 2.39 l/min. 'e clinical benefit of this approach
remains to be clarified, since the invasive techniques for
catheter placement cannot be eliminated. Several other
studies used invasive arterial blood pressure monitoring for
calibration of esCCOTM [16–18, 22, 23]. 'erefore, the
method cannot be considered noninvasive in these studies.
Our analysis of COesCCO revealed a percentage error of 47%








Count (number of patients), n 13 6 18 1 38
Male, n (%) 7 (54) 6 (100) 12 (67) 1 (100) 26 (68)
Age, years (median) and (IQR) 62 (55–73) 60 (51–69) 61 (47–72) 82 (82-82) 62 (50–72)
Weight, kg (median) and (IQR) 80 (75–90) 81 (71–88) 74 (58–83) 72 (72-72) 77 (70–84)





176 (165–180) 176 (176-176)
176
(168–180)
SAPS II (median) and (IQR) 42 (37–56) 41 (26–55) 45 (34–50) 65 (65-65) 45 (34–54)
Heart rate, beats/min (median) and (IQR) 94 (85–110) 84.5 (70–99) 85 (76–95) 114 (114-114) 90 (79–101)
Respiratory rate, breaths/min (median
(IQR))
18 (18–22) 16 (15–23) 18 (15–22) 20 (20-20) 18 (16–22)
Oxygen saturation, (%) (median (IQR)) 98 (95–99) 100 (99-100) 98 (96–98) 95 (95-95) 98 (96–100)
Mean arterial pressure, mmHg (median
(IQR))
70 (65–75) 77 (70–86) 77 (70–85) 95 (95-95) 75 (70–85)






128 (113–140) 160 (160-160)
120
(110–140)
Diastolic blood pressure, mmHg (median
(IQR))
55 (50–61) 55 (54–60) 60 (50–65) 60 (60-60) 57 (50–61)



















































































Figure 1: Comparison between COTPTD and COesCCO. (a) Correlation between COTPTD and COesCCO estimates at baseline. Each dot
represents one patient. Correlation between the two estimates was significant (r� 0.742, p< 0.001). 'e regression coefficient was 0.52, and
the intercept was 2.21 l/min (COesCCO� 0.52×COTPTD+ 2.21 l/min) indicating that at low CO, the esCCO was overestimated and at high
cardiac output, underestimated CO as compared to the TPTD method. (b) 'e Bland–Altman plot of COTPTD and COesCCO, Each dot
represents a pair of simultaneous cardiac output measurements by esCCO and TPTD of the same patient. 'e midhorizontal line marks the
average difference between COTPTD and COesCCO (bias; 1.61 l/min). 'e upper and lower horizontal lines represent the 95% confidence
interval of the difference between COTPTD and COesCCO (limits of agreement; −1.76 and +4.98 l/min). (c) 'e four quadrant plot of the
correlation betweenΔCOesCCO and ΔCOTPTD. Each dot represents the change of cardiac output over an 8-hour period (M8 h−Mmean baseline)
assessed by transpulmonary thermodilution (TPTD) and continuous cardiac output (esCCO). 'e regression fitted
(ΔCOesCCO� 0.35×ΔCOTPTD− 0.09 l/min) supported that a change in cardiac output overtime was underestimated by the esCCO as
compared to the TPTD method.
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compared with COTPTD, which above the maximum is
considered to be clinically acceptable (considered to be
>30% [14]).
Smetkin et al. [24] recently compared esCCOTM with
transpulmonary thermodilution by PiCCOTM in patients
during and after off-pump coronary artery bypass grafting
(OPCAB). Although OPCAB might not reflect a mixed ICU
population, as this population contained no high output
failures, the study reported limited agreement between the
techniques with a bias of 0.9 l/min, limits of agreement of
−0.9 l/min and +3.7 l/min, and a percentage error of 57%.
Our second goal was to assess the trending ability of
esCCOTM. 'e detection of changes in cardiac output is a
key aim of CO assessment, especially in patients with sepsis,
for the assessment of volume responsiveness. 'e trending
ability of esCCOTM has been tested in several studies,
showing clinically acceptable results in stable patients during
elective surgery [17, 18, 22], whereas the trending ability of
esCCOTM in ICU patients was reported to be unreliable
[19, 25, 26]. In our study, esCCOTM failed to detected
changes in cardiac output from baseline at a clinically ac-
ceptable rate. Only a weak correlation between ΔCOesCCO
and ΔCOTPTD was found (r� 0.442). An adjusted r2 of 0.195
shows that only around 20% of the variability estimated by
COesCCO can be explained by changes observed by COTPTD.
We further found that esCCOTMunderestimates changes in
CO by a factor of nearly three. 'e concordance rate was
74%, meaning that in 74% of patients, both the methods
registered changes in the same direction. 'is is, however,
too low, since only rates ≥90% are considered sufficient to
guide the therapy [15].
Our third aim was to assess the esCCOTM method in
patients with different medical conditions. Frequent indi-
cations for monitoring CO include sepsis and polytrauma.
Differences in pathophysiology potentially affect measure-
ments of the pulse-wave transit time method and reduce its
accuracy. In this study, the esCCOTM method did not yield




























































































































































Figure 2: Comparison between COTPTD and COesCCO in patients with sepsis (a–c) and patients with neither sepsis nor trauma (d–f). (a) In
patients with sepsis, correlation between COTPTD and COesCCO estimates at baseline was significant (r� 0.813, p � 0.001), regression
coefficient was 0.59, and the intercept was 1.82 l/min (COesCCO� 0.59×COTPTD+ 1.82 l/min); (d) in patients with neither sepsis nor
trauma, correlation was significant (r� 0.669, p � 0.002), regression coefficient was 0.41, and the intercept was 2.75 l/min
(COesCCO� 0.41×COTPTD+ 2.75 l/min). In patients with sepsis (b) comparing COTPTD and COesCCO yielded a bias of 1.52 l/min and
limits of agreement of −2.08 and +5.12 l/min; in patients with neither sepsis nor trauma (e), bias was 1.77 l/min and limits of agreement of
−1.81 and +5.34 l/min. Estimates of the change in CO over the first 8 h (M8 h –Mmean baseline) was analyzed by four quadrant plots with
regressions fitted. In patients with sepsis (c), ΔCOesCCO� 0.24×ΔCOTPTD– 0.27 l/min, and for patients with neither sepsis nor trauma
(f), ΔCOesCCO� 0.35×ΔCOTPTD+ 0.02 l/min.
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subgroups (sepsis, polytrauma, and nonsepsis/non-
polytrauma). Further, in each subgroup, the TPTD and
esCCOTM trends in cardiac output did not correlate sig-
nificantly. Further, in each subgroup, trends in cardiac
output did not correlate significantly between TPTD and
esCCOTM. Several studies have reported a negative cor-
relation between bias and systemic vascular resistance (SVR)
[18, 19, 26] and questioned its usefulness in situations with a
variable systemic vascular resistance. On the other hand, in
settings with stable SVR, esCCOTM does not offer any
benefit to mean arterial pressure readings [25].
Our study has several limitations. First, as a reference
method, our “gold standard,” was the TPTD and pulse
contour analysis, although both have their limitations.
Nevertheless, TPTD is accurate [27] and can detect changes
in CO comparable to a PAC [28, 29]. Second, we did not
measure SVR or the use of vasoactive drugs, which may
have influenced esCCOTM estimates [16]. 'ird, we an-
alyzed a small population that was heterogenous in terms of
clinical conditions and comorbidities. 'is makes it hard to
identify the causes of the poor agreement and trending
ability. Furthermore, the small sample size and related low
analytic power precludes identification of potential sub-
groups, in which esCCOTM would yield clinically ac-
ceptable CO estimates. Future studies should focus on the
strengths and weaknesses of esCCOTM in various settings
to find a potential field of application in the setting of
critical care.
5. Conclusion
In a mixed population of critically ill patients, the esti-
mated continuous CO using the noninvasive method of
pulse-wave transit time has low accuracy, low precision,
and poor trending ability as compared with trans-
pulmonary thermodilution and the pulse contour analy-
sis. An acceptable agreement and trending ability could




esCCOTM: Estimated continuous cardiac output
TPTD: Transpulmonary thermodilution.
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